Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
NCT00453271 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 443
Last updated 2013-05-23
Summary
The purpose of the study is to determine whether NB002, 0.25%, and 0.5% are safe and effective in the treatment of distal subungual onychomycosis of the toenail.
Conditions
- Onychomycosis
Interventions
- DRUG
-
NB-002
- DRUG
-
Vehicle control
Sponsors & Collaborators
-
NanoBio Corporation
lead INDUSTRY
Principal Investigators
-
Alicia Barba, MD · International Dermatology Research, Inc.
-
Alicia Bucko, DO · Academic Dermatology Associates
-
Richard Pollak, DPM, MS · Endeavor Clinical Trials, PA
-
Michael Jarratt, MD · Derm Research, PLLC
-
Terry Jones, MD · J & S Studies, Inc.
-
Robert Kaylor, DPM · Welborne Clinic
-
Steven Kempers, MD · Minnesota Clinical Study Center
-
Robert Matheson, MD · Oregon Medical Research Center, PC
-
Brock McConnehey,, DO · Northwest Clinical Trial
-
David Pariser, MD · Virginia Clinical Research, Inc.
-
Phoebe Rich, MD · Oregon Dermatology and Research Center
-
Dan Stewart, DO · Michigan Center for Research Corp
-
Leonard Swinyer, MD · Dermatology Research Center, Inc.
-
Robert Bissonette, MD · Innovaderm Research Inc.
-
Sylvia Garnis-Jones, MD · EntraLogix Clinical Group Inc.
-
David Gratton, MD · International Dermatology Research, Inc.
-
Lyn Guenther, MD · The Guenther Dermatology Research Centre
-
Rod Kunynetz, MD · Ultranova Skincare
-
Charles Lynde, MD · Lynderm Research, Inc.
-
Richard Langley, MD · Eastern Canada Cutaneous Research Associates, LTD
-
Kim Papp, MD · K. Papp Clinical Research
-
Yves Poulin, MD · Centre de Reeberche Dermatologique du Quebec Metropolitain (CRDQ)
-
Wayne Gulliver, MD · Newlab Clinical Research Inc.
-
R G Sibbald, MD · Dermatology Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2008-10-31
- Completion
- 2008-10-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
TDT 067 Onychomycosis Study
NCT01145807 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail
NCT00443820 ·Status: COMPLETED ·Phase: PHASE3
-
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
NCT05279846 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of the Systemic Absorption of MOB015B
NCT03244280 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail
NCT02343627 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Different Doses of a Novel Treatment for Onychomycosis
NCT00679770 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
NCT07065773 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
NCT01814020 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis
NCT00680134 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Swift Microwave Device for Onychomycosis
NCT05674747 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail
NCT01400594 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
NCT04188574 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
NCT01302119 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis
NCT00730405 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis
NCT01246518 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of ME1111 in Patients With Onychomycosis
NCT02022215 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis
NCT01080079 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
NCT02933879 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
NCT02866032 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis
NCT01431820 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine/Ketoconazole
NCT01615913 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis
NCT06327295 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Different Doses of a Novel Treatment for Onychomycosis
NCT00679965 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis
NCT00459537 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis
NCT03814343 ·Status: COMPLETED ·Phase: PHASE4